Friday, March 16, 2018 9:15:02 PM
BioAdaptives (OTC PINK: BDPT) Announces New Management
https://finance.yahoo.com/news/bioadaptives-otc-pink-bdpt-announces-100000748.html
LAS VEGAS, March 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol BDPT (OTC PINK:BDPT) announced that Mr. Kim D. Southworth has assumed the position of Chief Executive Officer of the Company upon the resignation of Mr. Christopher Hall. Dr. Edward E Jacobs, Jr. has been selected to be the Company’s Scientific Director.
Both Mr. Southworth and Dr. Jacobs have also been appointed to the Board replacing Mr. Barry Epling, who has resigned. Epling and Ferris Holding, Inc separately and together are now beneficial owners of less than 10% of the Company’s stock.
In announcing the changes, Southworth said, “I am pleased for this opportunity to guide the Company in forwarding its research, development and finally bringing a proprietary line of products to market. BioAdaptives is also actively looking at acquisitions both in US and Internationally for companies in the research, development, and manufacturing of dietary supplements and functional food.”
Southworth further added, “We are also in the process of finishing the accounting to bring the Company current in its reporting.”
Dr. Jacobs commented, “I am pleased to join BioAdaptives, Inc to oversee its research, testing, trials and clinical studies. We look forward to bringing to market a unique, effective line of products for human and animal consumption.”
Biographical Information for Mr. Southworth and Dr. Jacobs can be found on the BioAdaptives’ website: www.bioadaptives.com
SAFE HARBOR ACT
Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of BioAdaptives, Inc. and its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond BioAdaptives, Inc.'s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in BioAdaptives, Inc.'s filings with the Securities and Exchange Commission.
Investor Relations
BioAdaptives, Inc.
1-833-278-2378
ir@BioAdaptives.com
SOURCE: BioAdaptives, Inc.
Recent BDPT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 01:22:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 05:31:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 10:00:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 08:10:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:06:28 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 10/11/2023 07:59:24 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM